Retinal imaging in Alzheimer's disease.

Journal of Neurology, Neurosurgery, and Psychiatry
Carol Y CheungTien Yin Wong

Abstract

Identifying biomarkers of Alzheimer's disease (AD) will accelerate the understanding of its pathophysiology, facilitate screening and risk stratification, and aid in developing new therapies. Developments in non-invasive retinal imaging technologies, including optical coherence tomography (OCT), OCT angiography and digital retinal photography, have provided a means to study neuronal and vascular structures in the retina in people with AD. Both qualitative and quantitative measurements from these retinal imaging technologies (eg, thinning of peripapillary retinal nerve fibre layer, inner retinal layer, and choroidal layer, reduced capillary density, abnormal vasodilatory response) have been shown to be associated with cognitive function impairment and risk of AD. The development of computer algorithms for respective retinal imaging methods has further enhanced the potential of retinal imaging as a viable tool for rapid, early detection and screening of AD. In this review, we present an update of current retinal imaging techniques and their potential applications in AD research. We also discuss the newer retinal imaging techniques and future directions in this expanding field.

References

Dec 13, 2000·Brain Research. Brain Research Reviews·J C de la Torre, G B Stefano
Oct 26, 2010·Trends in Biotechnology·Christian Humpel
Mar 23, 2012·Journal of Neuropathology and Experimental Neurology·Thomas G BeachWalter Kukull
Mar 30, 2012·The New England Journal of Medicine·David A AntonettiThomas W Gardner
Oct 23, 2012·Neurobiology of Aging·Leif ØstergaardMark J West
Oct 27, 2012·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Carol Yim-lui CheungTien Yin Wong
Nov 21, 2012·Nature Reviews. Neurology·Anat LondonMichal Schwartz
Feb 28, 2013·Translational Psychiatry·S Frost AIBL Research Group
Dec 24, 2013·Neuron·Clifford R Jack, David M Holtzman
Jan 15, 2014·Journal of Alzheimer's Disease : JAD·Zhongyong ShiYuan Shen
Jan 21, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Carol Yim-Lui CheungTien Yin Wong
Jun 18, 2014·Neuroscience Letters·Saima HilalMohammad Kamran Ikram
Oct 10, 2014·Dementia and Geriatric Cognitive Disorders Extra·Yi-Ting OngMohammad Kamran Ikram
Dec 3, 2014·Neuroscience Letters·Yi-Ting OngMohammad Kamran Ikram
Aug 5, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Eric R SiemersRonald Demattos
Oct 9, 2015·Seminars in Neurology·Carol Y CheungTien Y Wong
Oct 21, 2015·Journal of Alzheimer's Disease : JAD·Bruno DuboisGrazia Dell'Agnello
Oct 28, 2015·Annals of Neurology·Chiara La MorgiaValerio Carelli
Dec 15, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Leif ØstergaardKeith W Muir
Aug 30, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association
Apr 12, 2017·JAMA : the Journal of the American Medical Association·Rebecca F GottesmanThomas H Mosley
Jul 20, 2017·Lancet Neurology·Giovanni B FrisoniBengt Winblad
Jul 25, 2017·Lancet·Gill LivingstonNaaheed Mukadam
Oct 5, 2017·Neurobiology of Aging·Unal MutluM Kamran Ikram
Nov 4, 2017·Lancet Neurology·Hussein N Yassine
Apr 6, 2018·Ophthalmic Research·Lajos CsincsikImre Lengyel
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
Jan 16, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Melanie D SweeneyBerislav V Zlokovic
Apr 12, 2019·Investigative Ophthalmology & Visual Science·Samuel AsanadAlfredo A Sadun
Apr 20, 2019·The British Journal of Ophthalmology·Shi Song RongDanny Siu-Chun Ng
Jun 30, 2019·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Jurre den HaanFemke H Bouwman
Jul 17, 2019·Ophthalmology·Yoshikazu ItoShoichiro Tsugane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Related Papers

International Journal of Retina and Vitreous
Leonardo Provetti CunhaMário L R Monteiro
Frontiers in Neuroscience
Nazanin MirzaeiMaya Koronyo-Hamaoui
Progress in Retinal and Eye Research
Amir H KashaniJohn M Ringman
American Journal of Ophthalmology
Cecilia S Lee, Rajendra S Apte
Medicina
Alicia López-de-EguiletaAlfonso Casado
© 2021 Meta ULC. All rights reserved